2022. A NOVEL FORMULATION DESIGN FOR EXTENDED RELEASE TABLET OF ETODOLAC FOR THE TREATMENT OF RHEUMATOID ARTHRITIS. Journal of Pharmaceutical Negative Results. (Sep. 2022), 972–979. DOI:https://doi.org/10.47750/pnr.2022.13.S01.116.